Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
32 Percent of Dementia Attributed to Audiometric Hearing Loss
No association seen for self-reported hearing loss with increased risk for dementia in community-dwelling seniors during up to eight years of follow-up
Dementia Biomarkers Associated With Age, Sex, APOE ε4 Status
Age associated with P-tau181, NfL, and GFAP; significant association seen for APOE ε4 status with P-tau181, GFAP
Supreme Court Case Targets Free Preventive Care Provided by the Affordable Care Act
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them
Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya
Digital Technology Linked to Lower Rates of Cognitive Decline in Adults Older Than 50
Use of digital technologies also associated with reduced time-dependent rates of cognitive decline
Air Pollution Exposure Negatively Impacts Some Domains of Cognitive Performance
Strongest relationship seen for air pollution and language
2013 to 2022 Saw Increase in Group A Streptococcal Infections
Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents
17 Modifiable Risk Factors Shared by Stroke, Dementia, and Late-Life Depression
Authors say these factors can inform steps individuals can take to lower their risks for age-related brain diseases
